BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18248882)

  • 1. Molecular pathology of the FSH receptor: new insights into FSH physiology.
    Meduri G; Bachelot A; Cocca MP; Vasseur C; Rodien P; Kuttenn F; Touraine P; Misrahi M
    Mol Cell Endocrinol; 2008 Jan; 282(1-2):130-42. PubMed ID: 18248882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?
    Delbaere A; Smits G; Olatunbosun O; Pierson R; Vassart G; Costagliola S
    Hum Reprod; 2004 Mar; 19(3):486-9. PubMed ID: 14998941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core fucosylation regulates the ovarian response via FSH receptor during follicular development.
    Wang T; Zhang Z; Qu C; Song W; Li M; Shao X; Fukuda T; Gu J; Taniguchi N; Li W
    J Adv Res; 2024 Jan; ():. PubMed ID: 38280716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FSH and eCG impact follicles development and expression of ovarian FSHR and caspase-9 in mice.
    Wei S; Gong Z; Guo H; Zhang T; Ma Z
    Iran J Vet Res; 2017; 18(2):79-85. PubMed ID: 28775745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of accelerated ovarian aging in a follicle-stimulating hormone receptor haploinsufficiency model.
    Mehalko K; Kim M; Paye S; Koh K; Lu RJ; Benayoun BA
    Transl Med Aging; 2023; 7():1-8. PubMed ID: 36714222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy.
    Bordoloi D; Bhojnagarwala PS; Perales-Puchalt A; Kulkarni AJ; Zhu X; Liaw K; O'Connell RP; Park DH; Kulp DW; Zhang R; Weiner DB
    JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36509287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene.
    Lussiana C; Guani B; Mari C; Restagno G; Massobrio M; Revelli A
    Obstet Gynecol Surv; 2008 Dec; 63(12):785-95. PubMed ID: 19017414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and clinical consequences of mutations in the FSH receptor.
    Gromoll J; Simoni M; Nordhoff V; Behre HM; De Geyter C; Nieschlag E
    Mol Cell Endocrinol; 1996 Dec; 125(1-2):177-82. PubMed ID: 9027356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models.
    Siegel ET; Kim HG; Nishimoto HK; Layman LC
    Reprod Sci; 2013 Mar; 20(3):211-33. PubMed ID: 23184658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations and polymorphisms in FSH receptor: functional implications in human reproduction.
    Desai SS; Roy BS; Mahale SD
    Reproduction; 2013 Dec; 146(6):R235-48. PubMed ID: 24051057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Action of FSH.
    Casarini L; Crépieux P
    Front Endocrinol (Lausanne); 2019; 10():305. PubMed ID: 31139153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature ovarian failure and tissue engineering.
    Ghahremani-Nasab M; Ghanbari E; Jahanbani Y; Mehdizadeh A; Yousefi M
    J Cell Physiol; 2020 May; 235(5):4217-4226. PubMed ID: 31663142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current approaches for the treatment of premature ovarian failure with stem cell therapy.
    Sheikhansari G; Aghebati-Maleki L; Nouri M; Jadidi-Niaragh F; Yousefi M
    Biomed Pharmacother; 2018 Jun; 102():254-262. PubMed ID: 29567538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Vaccination against Recombinant FSH or LH Receptor Subunits on Gonadal Development and Functioning Male Rats.
    Pan F; Fu W; Zhang B; Han M; Xie H; Yi Q; Qian W; Cui J; Cao M; Li Y; Jia Y; Fang F; Ling Y; Li Y; Liu Y
    Vet Sci; 2024 Apr; 11(4):. PubMed ID: 38668443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactivity and Pharmacodynamics of X002, a Follicle-stimulating Hormone-IgG4 Fc Fusion Protein.
    Xu G; Yang Y; Liu Y; Chen F; Dong L; Wan D; Li H; Yang C; Gao X
    Comp Med; 2023 Apr; 73(2):145-52. PubMed ID: 37072182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput Sequencing to Identify Monogenic Etiologies in a Preselected Polycystic Ovary Syndrome Cohort.
    Crespo RP; Rocha TP; Montenegro LR; Nishi MY; Jorge AAL; Maciel GAR; Baracat E; Latronico AC; Mendonca BB; Gomes LG
    J Endocr Soc; 2022 Sep; 6(9):bvac106. PubMed ID: 35898701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azoospermic men with isolated elevation of folliclestimulating hormone represent a specific subpopulation of patients with poor reproductive outcomes.
    Gamidov S; Shatylko T; Popova A; Gasanov N; Sukhikh G
    Clin Exp Reprod Med; 2022 Mar; 49(1):62-69. PubMed ID: 35172538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Roles of Luteinizing Hormone, Follicle-Stimulating Hormone and Testosterone in Spermatogenesis and Folliculogenesis Revisited.
    Oduwole OO; Huhtaniemi IT; Misrahi M
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celastrol Prevents Oxidative Stress Effects on FSHR, PAPP, and CYP19A1 Gene Expression in Cultured Human Granulosa-Lutein Cells.
    Martín-Ramírez R; González-Fernández R; Rotoli D; Hernández J; Martín-Vasallo P; Palumbo A; Ávila J
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of FSHR polymorphisms on premature ovarian insufficiency in human beings: a meta-analysis.
    Huang W; Cao Y; Shi L
    Reprod Biol Endocrinol; 2019 Oct; 17(1):80. PubMed ID: 31629411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.